Watts GS - Search Results

1

Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.

Bixby B, Vrba L, Lenka J, Oshiro MM, Watts GS, Hughes T, Erickson H, Chopra M, Knepler JL, Knox KS, Jarnagin L, Alalawi R, Kala M, Bernert R, Routh J, Roe DJ, Garland LL, Futscher BW, Nelson MA. Bixby B, et al. Among authors: watts gs. Sci Rep. 2024 Feb 5;14(1):2939. doi: 10.1038/s41598-024-53132-x. Sci Rep. 2024. PMID: 38316884 Free PMC article.

2

Cell-Free DNA Methylation Analysis as a Marker of Malignancy in Pleural Fluid.

Bixby B, Vrba L, Lenka J, Oshiro M, Watts GS, Hughes T, Erickson H, Chopra M, Knepler JL, Knox KS, Jarnagin L, Alalawi R, Kala M, Bernert R, Routh J, Roe DJ, Garland LL, Futscher BW, Nelson MA. Bixby B, et al. Among authors: watts gs. Res Sq [Preprint]. 2023 Oct 9:rs.3.rs-3390107. doi: 10.21203/rs.3.rs-3390107/v1. Res Sq. 2023. Update in: Sci Rep. 2024 Feb 5;14(1):2939. doi: 10.1038/s41598-024-53132-x PMID: 37886511 Free PMC article. Updated. Preprint.

3

Liquid biopsy, using a novel DNA methylation signature, distinguishes pancreatic adenocarcinoma from benign pancreatic disease.

Vrba L, Futscher BW, Oshiro M, Watts GS, Menashi E, Hu C, Hammad H, Pennington DR, Golconda U, Gavini H, Roe DJ, Shroff RT, Nelson MA. Vrba L, et al. Among authors: watts gs. Clin Epigenetics. 2022 Feb 22;14(1):28. doi: 10.1186/s13148-022-01246-2. Clin Epigenetics. 2022. PMID: 35193708 Free PMC article.

4

Detecting differences in 5-methylcytosine using restriction enzyme isoschizomers: an endogenous control for complete digestion.

Watts GS, Futscher BW. Watts GS, et al. Nucleic Acids Res. 1995 Nov 25;23(22):4740-1. doi: 10.1093/nar/23.22.4740. Nucleic Acids Res. 1995. PMID: 8524671 Free PMC article.

5

Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.

Junk DJ, Vrba L, Watts GS, Oshiro MM, Martinez JD, Futscher BW. Junk DJ, et al. Among authors: watts gs. Neoplasia. 2008 May;10(5):450-61. doi: 10.1593/neo.08120. Neoplasia. 2008. PMID: 18472962 Free PMC article.

6

Agglomerative epigenetic aberrations are a common event in human breast cancer.

Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW. Novak P, et al. Among authors: watts gs. Cancer Res. 2008 Oct 15;68(20):8616-25. doi: 10.1158/0008-5472.CAN-08-1419. Cancer Res. 2008. PMID: 18922938 Free PMC article.

7

Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.

Oshiro MM, Watts GS, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, Domann FE, Futscher BW. Oshiro MM, et al. Among authors: watts gs. Oncogene. 2003 Jun 5;22(23):3624-34. doi: 10.1038/sj.onc.1206545. Oncogene. 2003. PMID: 12789271

8

The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.

Watts GS, Oshiro MM, Junk DJ, Wozniak RJ, Watterson S, Domann FE, Futscher BW. Watts GS, et al. Neoplasia. 2004 May-Jun;6(3):187-94. doi: 10.1593/neo.3292. Neoplasia. 2004. PMID: 15153330 Free PMC article.

9

Epigenetic inactivation of the HOXA gene cluster in breast cancer.

Novak P, Jensen T, Oshiro MM, Wozniak RJ, Nouzova M, Watts GS, Klimecki WT, Kim C, Futscher BW. Novak P, et al. Among authors: watts gs. Cancer Res. 2006 Nov 15;66(22):10664-70. doi: 10.1158/0008-5472.CAN-06-2761. Epub 2006 Nov 6. Cancer Res. 2006. PMID: 17090521

10

DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.

Watts GS, Futscher BW, Holtan N, Degeest K, Domann FE, Rose SL. Watts GS, et al. BMC Med Genomics. 2008 Sep 30;1:47. doi: 10.1186/1755-8794-1-47. BMC Med Genomics. 2008. PMID: 18826610 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters